13.3 Preoperative Medical Evaluation & Pre-Participation Sports Exam

Preoperative Cardiovascular Risk Assessment: ACC/AHA Framework

The primary purpose of the preoperative medical evaluation is not to "clear" a patient for surgery, but to provide an objective, evidence-based assessment of perioperative risk, identify unrecognized medical comorbidities, and optimize clinical management. Cardiovascular complications—including myocardial infarction, acute decompensated heart failure, and malignant arrhythmias—represent the leading causes of perioperative morbidity and mortality in noncardiac surgery.

The 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management outlines a structured, stepwise decision-making algorithm:

Stepwise Algorithmic Approach

1. Step 1: Surgical Urgency

   • Emergency Surgery (life or limb threatened without intervention within $<6$ hours): Proceed directly to the operating room. There is no time for noninvasive cardiac testing. Provide clinical surveillance, perioperative hemodynamic monitoring, and postoperative cardiac enzyme surveillance.
   • Urgent Surgery (within 6 to 24 hours): Proceed with focused medical optimization; testing is rarely indicated.
   • Elective Surgery: Proceed to Step 2.

2. Step 2: Identify Active / Unstable Cardiac Conditions Elective noncardiac surgery must be postponed for diagnostic evaluation and medical stabilization if any of the following active conditions are identified:

   • Unstable Coronary Syndromes: Unstable or severe angina (Canadian Cardiovascular Society [CCS] Class III or IV), recent acute myocardial infarction ($<30$ days) with residual ischemia.
   • Decompensated Heart Failure: New-onset heart failure, worsening dyspnea at rest (NYHA Class IV), physical exam signs of volume overload (elevated jugular venous distention, S3 gallop, bibasilar pulmonary crackles, progressive peripheral edema).
   • Significant Symptomatic Arrhythmias: High-grade atrioventricular block (Mobitz Type II or third-degree AV block), symptomatic ventricular tachyarrhythmias, uncontrolled supraventricular arrhythmias (e.g., atrial fibrillation with rapid ventricular response $>110$ bpm).
   • Severe Symptomatic Valvular Heart Disease: Specifically severe symptomatic aortic stenosis (aortic valve area $<1.0\text{ cm}^2$, mean transvalvular gradient $>40\text{ mm Hg}$, or jet velocity $>4.0\text{ m/s}$ with angina, syncope, or heart failure symptoms). Severe aortic stenosis carries a 10% to 30% risk of perioperative cardiac death or infarction and mandates surgical or transcatheter aortic valve replacement prior to elective noncardiac procedures.

3. Step 3: Surgical Procedural Risk Stratification

   • Low-Risk Surgery ($<1%$ Combined 30-Day Risk of MACE [Cardiac Death or Nonfatal MI]): Cataract extraction, superficial dermatologic surgery, breast biopsy/lumpectomy, minor plastic surgery, ambulatory orthopedic procedures, diagnostic endoscopy. Management: Proceed directly to surgery without additional cardiac testing, regardless of underlying patient comorbidities.
   • Elevated-Risk Surgery ($\ge 1%$ Combined 30-Day Risk of MACE): Intraperitoneal operations (colectomy, gastrectomy, exploratory laparotomy), intrathoracic procedures (pneumonectomy, lobectomy), vascular procedures (open abdominal aortic aneurysm repair, suprainguinal bypass), major orthopedic surgery (total hip or knee arthroplasty), head and neck oncologic resections. Management: Proceed to Step 4.

4. Step 4: Functional Capacity Assessment in Metabolic Equivalents (METs) Functional capacity is quantified using Metabolic Equivalents of Task (METs), where 1 MET represents the resting metabolic rate (oxygen uptake of approximately 3.5 mL O₂/kg/min):

   • Functional Threshold (4 METs): An individual has preserved functional capacity ($\ge 4\text{ METs}$) if they can climb a flight of stairs without stopping, walk up a steep hill, walk on level ground at 4 mph (6.4 km/h), carry heavy groceries upstairs, perform heavy household chores (e.g., scrubbing floors, vacuuming, moving furniture), or participate in moderate recreational activities (e.g., golfing without a cart, doubles tennis, dancing).
   • Clinical Rule: If a patient scheduled for elevated-risk surgery has functional capacity $\ge 4\text{ METs}$ without cardiac symptoms, they may proceed to surgery WITHOUT further cardiac testing, even in the presence of established cardiovascular comorbidities.
   • If functional capacity is poor ($<4\text{ METs}$) or unknown (e.g., sedentary, wheelchair-bound, severe joint pain limiting mobility), proceed to Step 5.

5. Step 5: Revised Cardiac Risk Index (RCRI / Lee Index) For patients with poor or unknown functional capacity undergoing elevated-risk surgery, assess the Revised Cardiac Risk Index (RCRI).

---

The Revised Cardiac Risk Index (RCRI / Lee Index)

The RCRI incorporates six independent clinical predictors of major adverse cardiac events (MACE), assigning 1 point to each predictor present:

1. High-Risk Surgical Procedure: Intraperitoneal, intrathoracic, or suprainguinal vascular surgery.
2. History of Ischemic Heart Disease: History of myocardial infarction, positive prior exercise stress test, current angina, nitrate use, or ECG demonstrating pathological Q waves.
3. History of Congestive Heart Failure: Current heart failure, history of pulmonary edema, paroxysmal nocturnal dyspnea, S3 gallop, bibasilar rales, or documented left ventricular ejection fraction (LVEF) $<40%$.
4. History of Cerebrovascular Disease: Prior transient ischemic attack (TIA) or stroke (ischemic or hemorrhagic).
5. Preoperative Insulin-Treated Diabetes Mellitus: Patient requires chronic insulin therapy. (Exam Pearl: Oral antidiabetic therapy alone does NOT score a point on the RCRI).
6. Preoperative Renal Insufficiency: Preoperative baseline serum creatinine $>2.0\text{ mg/dL}$ ($>177;\mu\text{mol/L}$).

RCRI Scoring & 30-Day MACE Stratification

THE DECISION-MAKING PEARL: Even in RCRI Class III or IV with poor functional capacity, pharmacologic cardiac stress testing (dobutamine stress echocardiography or pharmacologic myocardial perfusion scintigraphy) is indicated ONLY IF the test results will alter clinical management (e.g., the patient is a suitable candidate for, and would agree to undergo, coronary artery revascularization or delay of surgery). If revascularization would not be pursued regardless of findings, or if surgery cannot be delayed, stress testing produces unnecessary delays and false positives; the patient should proceed to surgery with medical optimization and perioperative hemodynamic monitoring.

---

High-Value Diagnostic Stewardship (Choosing Wisely Guidelines)

Both the American Academy of Family Physicians (AAFP) and the American College of Physicians (ACP), through the Choosing Wisely campaign, emphasize that routine preoperative "battery" testing in asymptomatic patients yields zero clinical benefit while generating false positives, unneeded subspecialty consultations, cancelled surgeries, and increased costs.

High-Yield Testing Recommendations

1. Routine Preoperative 12-Lead Electrocardiogram (ECG):

   • Choosing Wisely Rule: Do NOT obtain routine baseline ECGs in asymptomatic patients undergoing low-risk surgical procedures.
   • Appropriate Indications: ECG is indicated for patients undergoing elevated-risk surgery who have known cardiovascular disease, significant arrhythmias, peripheral artery disease, severe systemic comorbidity, or $\ge 1$ RCRI predictor.

2. Routine Complete Blood Count (CBC):

   • Choosing Wisely Rule: Do NOT order routine baseline CBC in healthy, asymptomatic patients.
   • Appropriate Indications: Anticipated substantial procedural blood loss ($>500\text{ mL}$), patients with clinical signs or symptoms of anemia, suspected myelosuppression, chronic liver or renal disease, or patients receiving active antineoplastic chemotherapy.

3. Routine Serum Chemistries & Renal Function (BMP):

   • Choosing Wisely Rule: Do NOT order routine electrolytes or creatinine in healthy patients.
   • Appropriate Indications: Known chronic kidney disease, diabetes mellitus, congestive heart failure, liver disease, or patients taking medications that alter renal function or electrolytes (e.g., ACE inhibitors, ARBs, diuretics, digoxin, lithium).

4. Routine Coagulation Studies (PT/INR and aPTT):

   • Choosing Wisely Rule: Do NOT order routine coagulation screening prior to surgery.
   • Evidence: Normal coagulation tests do NOT predict intraoperative or postoperative bleeding in patients with an unremarkable bleeding history. Testing is indicated ONLY if the patient has a personal or family history of abnormal bleeding/diathesis, end-stage liver disease, severe malabsorption/malnutrition, or is receiving active anticoagulant pharmacotherapy.

5. Routine Preoperative Chest Radiography (CXR):

   • Choosing Wisely Rule: Do NOT obtain routine screening chest radiographs.
   • Appropriate Indications: New or unstable cardiopulmonary symptoms (acute dyspnea, new cough, wheezing), suspected pneumonia, or decompensated chronic pulmonary disease.

---

Perioperative Medication Management

Managing chronic medications perioperatively requires balancing the risks of surgical bleeding and drug interactions against the risks of chronic disease destabilization:

Master Perioperative Medication Protocol

---

Pre-Participation Physical Evaluation (PPE) in Athletics

The primary clinical objective of the Pre-Participation Physical Evaluation (PPE) is to identify life-threatening medical conditions—most notably those predisposing to sudden cardiac death (SCD)—and to ensure safe participation in sports. The PPE should ideally be scheduled at least 6 weeks prior to the sports season to provide sufficient lead time for diagnostic workup, rehabilitation, or subspecialist consultation of identified abnormalities.

The AHA 14-Element Cardiovascular Screening Checklist

The American Heart Association (AHA) recommends that every athletic PPE include a thorough 14-element cardiovascular screen comprising personal history, family history, and physical examination:

Personal History (5 Elements)

1. Exertional chest pain or chest discomfort
2. Unexplained syncope, near-syncope, or severe exertional dizziness
3. Excessive, unexplained exertional dyspnea or fatigue out of proportion to conditioning
4. Prior detection of a heart murmur
5. Prior diagnosis of systemic hypertension

Family History (3 Elements)

1. Premature death (sudden, unexpected) before age 50 attributable to cardiovascular disease in $\ge 1$ relative
2. Disability from cardiovascular disease in a close relative under age 50
3. Specific knowledge of cardiac conditions in family members: hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy, long QT syndrome, Brugada syndrome, arrhythmogenic right ventricular cardiomyopathy (ARVC), Marfan syndrome, or clinically important arrhythmias

Physical Examination (6 Elements)

1. Heart Murmur Auscultation: Auscultation in both supine and standing (or during Valsalva maneuver) to differentiate innocent flow murmurs from obstructive hypertrophic cardiomyopathy
2. Femoral Arterial Pulse Palpation: Bilateral palpation to detect radial-femoral pulse delay or diminished femoral amplitude indicative of coarctation of the aorta
3. Stigmata of Marfan Syndrome: Pectus excavatum or carinatum, arachnodactyly, high-arched palate, arm span exceeding height (ratio $>1.05$), joint hypermobility, severe myopia/lens subluxation
4. Bilateral Seated Brachial Blood Pressure Measurement
5. History of prior restriction from athletic participation
6. History of prior cardiac testing ordered by a physician

---

Dynamic Murmur Auscultation: HCM vs. Innocent Murmurs

Distinguishing hypertrophic cardiomyopathy (the leading cause of sudden cardiac death in young athletes in North America) from benign physiologic flow murmurs is an essential clinical skill:

                          DYNAMIC AUSCULTATION IN ATHLETIC SCREENING
                          
  ┌────────────────────────────────────────────────────────────────────────────────────────┐
  │ HYPERTROPHIC CARDIOMYOPATHY (HCM)                                                      │
  │ • Murmur: Harsh, crescendo-decrescendo systolic murmur at left lower sternal border    │
  │ • Pathophysiology: Asymmetric septal hypertrophy causing dynamic LV outflow obstruction│
  │ • VALSALVA MANEUVER / STANDING (Decreased Venous Return / Decreased LV Volume):        │
  │   ➔ Left ventricular cavity narrows, subaortic obstruction worsens                     │
  │   ➔ MURMUR INTENSITY INCREASES                                                         │
  │ • SQUATTING / PASSIVE LEG RAISE (Increased Venous Return / Increased LV Preload):      │
  │   ➔ Expands left ventricular outflow tract, relieving obstruction                      │
  │   ➔ MURMUR INTENSITY DECREASES                                                         │
  └────────────────────────────────────────────────────────────────────────────────────────┘
                                              │
                                      Contrast With
                                              │
                                              ▼
  ┌────────────────────────────────────────────────────────────────────────────────────────┐
  │ INNOCENT / PHYSIOLOGIC FLOW MURMUR                                                     │
  │ • Murmur: Soft (Grade 1–2/6), early-to-midsystolic, vibratory/musical, LSB or pulmonic │
  │ • VALSALVA MANEUVER / STANDING (Decreased Preload):                                    │
  │   ➔ Transvalvular flow volume diminishes                                               │
  │   ➔ MURMUR INTENSITY DECREASES OR COMPLETELY DISAPPEARS                                │
  │ • SUPINE POSITIONING / SQUATTING:                                                      │
  │   ➔ Increased venous return enhances flow; MURMUR INCREASES                            │
  └────────────────────────────────────────────────────────────────────────────────────────┘

Aortic Stenosis Differentiation: Aortic stenosis produces a harsh systolic ejection murmur at the right upper sternal border that radiates to the carotids. Like innocent murmurs, aortic stenosis decreases in intensity with Valsalva (reduced transvalvular flow) and increases with squatting.

Athletic Clearance Categories

Upon completing the PPE, the physician assigns the athlete to one of four clearance categories:

1. Cleared without restriction for all sports.
2. Cleared with recommendations for further evaluation or treatment (e.g., cleared for track while beginning inhaled albuterol for exercise-induced bronchospasm).
3. Clearance deferred pending further evaluation (e.g., withholding clearance pending an echocardiogram to evaluate a murmur that intensifies with Valsalva).
4. Disqualified / Not cleared for specific or all sports (e.g., active acute myocarditis, severe symptomatic aortic stenosis, uncontrolled malignant arrhythmias).

---

Concussion Triage & Graduated Return-to-Play Protocol

A sport-related concussion is a traumatic brain injury induced by biomechanical forces. Clinical symptoms encompass somatic (headache, dizziness, nausea), cognitive (brain fog, amnesia, delayed processing), emotional (irritability, lability), and sleep disturbances.

• The Golden Rule: Any athlete who exhibits signs, symptoms, or suspicion of a concussion following head or body trauma MUST BE REMOVED FROM PLAY IMMEDIATELY. Under no circumstances is an athlete allowed to return to play on the same day ("When in doubt, sit them out").
• Evaluation: Utilize standardized tools such as the Sport Concussion Assessment Tool 6 (SCAT6) or Child SCAT6.
• Graduated Return-to-Play (RTP) Protocol: Once the athlete has completed a brief 24- to 48-hour period of initial cognitive and physical rest and is symptom-free at rest, they may begin the structured 6-Stage Return-to-Play Protocol. Each stage requires a minimum of 24 hours. If concussion symptoms recur at any stage, activity must stop, the athlete rests for at least 24 hours until asymptomatic, and resumes at the previous asymptomatic stage:

  Stage 1: Symptom-Limited Activity
  • Daily light walking, gentle cognitive activities; avoid vigorous exercise and screen overuse.
     │ (Minimum 24 hours asymptomatic)
     ▼
  Stage 2: Light Aerobic Exercise
  • Stationary cycling or walking at slow-to-medium pace; heart rate <70% max; NO resistance training.
     │ (Minimum 24 hours asymptomatic)
     ▼
  Stage 3: Sport-Specific Exercise
  • Running drills (soccer, basketball) or skating drills (hockey); NO head impact activities.
     │ (Minimum 24 hours asymptomatic)
     ▼
  Stage 4: Non-Contact Training Drills
  • More complex training drills (passing, agility); initiation of progressive resistance training.
     │ (Minimum 24 hours asymptomatic)
     ▼
  Stage 5: Full-Contact Practice
  • MANDATORY MEDICAL CLEARANCE REQUIRED; normal training activities and contact drills.
     │ (Minimum 24 hours asymptomatic)
     ▼
  Stage 6: Return to Competition
  • Normal game play and full unrestricted athletic competition.